PEARL BIO, INC. — Department of Defense STTR Phase I: SMALL BUSINESS TECHNOLOGY TRANSFER RESEARCH (STTR) SERVICES PHASE I EFFORT TITLED SCALABLE
PEARL BIO, INC. — STTR Phase I award from Department of Defense.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $249,967. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Materials & Manufacturing. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Pearl Bio, Inc. received STTR Phase I funding to develop a scalable method for producing sequence-defined biopolymers that incorporate aramid materials. The project uses genomically recoded biological systems to enable efficient manufacturing of these advanced polymers.
- Amount
- $249,967
- Agency
- Department of Defense · Department of the Army
- Program / Phase
- STTR · Phase I
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MA
- Period
- 2026-04-01 → 2027-03-31
Technology domains
Description
SMALL BUSINESS TECHNOLOGY TRANSFER RESEARCH (STTR) SERVICES PHASE I EFFORT TITLED SCALABLE PRODUCTION OF SEQUENCE-DEFINED BIOPOLYMERS CONTAINING ARAMIDS IN GENOMICALLY RECODED SYSTEMS.